Loading...
Search Filters
Date Range
toReport Types
Condition
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 8 of 8
Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma
Drug Des Devel Ther. 2015 Nov 4;9:5925-32
Ifosfamide not necessary in chemotherapy for nonmetastatic osteosarcoma
J Clin Oncol. 2012 Jun 10;30(17):2112-8. doi: 10.1200/JCO.2011.38.4420. Epub 2012 May 7
Osteosarcoma: methotrexate & doxorubicin versus methotrexate, etoposide & ifosfamide
Eur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30
Muramyl tripeptide in chemotherapy improves overall osteosarcoma survival
J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095
Ewing sarcoma treatment: assessment of cyclophosphamide and etoposide on survival rates
J Clin Oncol. 2008 Sep 20;26(27):4385-93. doi: 10.1200/JCO.2008.16.5720
MTP-PE added to chemotherapy did not improve outcomes in metastatic osteosarcoma patients
Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566
Ewing sarcoma: Similar survival rates with intensified dose regimen of VDC/IE
J Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6
Interval-compressed chemotherapy effective in treatment of localized Ewing sarcoma
J Clin Oncol. 2012 Nov 20;30(33):4148-54. doi: 10.1200/JCO.2011.41.5703. Epub 2012 Oct 22
Showing 1 - 8 of 8